In the News
Moving closer to dynamic drug development through automated solutions
Robert King explains that solutions are on the horizon that will help overcome the current bottlenecks and other challenges that are occurring in early drug development.
Health equity in pharma: communities most impacted by racial bias
Rose Blackburne discusses health equity and racial bias in pharma and how to address inequities in access and care.
CRO industry report
Our experts comment on the challenges, trends and focus of clinical research today.
CGT demands vision, partnership and patient-centricity to transform healthcare
Panteli Theocharous discusses the current landscape and future outlook for clinical research in cell and gene therapy, stressing the importance of partnerships with various stakeholders.
Measuring vaccine efficacy: the right endpoints are key to success
Endpoints are needed throughout the vaccine development life cycle. In this article, the authors discuss how to develop, assess and select endpoints at each development step.
Navigating the changing regulatory landscape for laboratory-developed tests: a CRO lab perspective
Poluru Reddy and Anup Madan discuss the vital role laboratory-developed tests often play in drug development and clinical trials.
Flow cytometry: a bioanalytical platform for cell and gene therapy
The authors discuss the powerful technology that flow cytometry offers the emerging cell and gene therapies field.
A reliable method for quantitating extractables and leachables in medical and pharmaceutical-grade plastics
This article presents the use of charged aerosol detection combined with LC/UV-MS to obtain a more complete E&L profile.
IVD manufacturers are being put to the test
PPD clinical research business experts comment on how the COVID-19 pandemic has accelerated the trend toward home diagnostics and raised the bar for faster, more detailed test results.
